| |
| Magyar Osteológiai és Osteoarthrológiai Társaság |
|
| Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease |
 Rendezvény kezdete: 2005.07.06. | Rendezvény vége: 2005.07.07. |
| Helyszín: Oxford |
| A rendezvény Web oldala: http://www.paget.org.uk |
Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment |
|
|
 |
| |
| Magyar Osteológiai és Osteoarthrológiai Társaság |
|
| Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease |
| Rendezvény kezdete: 2005.07.06. | Rendezvény vége: 2005.07.07. |
| Helyszín: Oxford |
| A rendezvény Web oldala: http://www.paget.org.uk |
Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment |
|
|
|
| |
| Magyar Osteológiai és Osteoarthrológiai Társaság |
|
| Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease |
| Rendezvény kezdete: 2005.07.06. | Rendezvény vége: 2005.07.07. |
| Helyszín: Oxford |
| A rendezvény Web oldala: http://www.paget.org.uk |
Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment |
|
|
|
| |
| Magyar Osteológiai és Osteoarthrológiai Társaság |
|
| Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease |
| Rendezvény kezdete: 2005.07.06. | Rendezvény vége: 2005.07.07. |
| Helyszín: Oxford |
| A rendezvény Web oldala: http://www.paget.org.uk |
Deadline for abstracts: 11 February 2005
For full details and abstract submission form please see the Symposium website.
Speakers to include:
Roland Baron (New Haven, USA): Approaches to anabolic agents for bone
Roger Bouillon (Leuven, Belgium): Advances in Vitamin D pharmacology
Henry Bryant (Indianapolis, USA): SERMs Where next?
Hal Ebetino (Cincinnati, USA): The applications of phosphonate chemistry to bone pharmacology
Lorie Fitzpatrick (Thousand Oaks, USA): Therapeutic strategies based on blockade of the RANKL/RANK/OPG system
Ross Garrett (San Antonio, USA): Approaches to anabolic drugs via statins and the proteasome pathways
Anthony Hollander (Bristol, UK): Engineering new tissues for bone and joint disease
Stephen Krane (Boston USA): Current and future therapies in arthritis and connective tissue disease
Donald McDonnell (Durham, USA): Estrogen receptor pharmacology
Gregory Mundy (San Antonio, USA): Pharmacological approaches to interfering with tumour cell interactions in bone
Ed Nemeth (Toronto, Canada): The calcium sensing receptor as a drug target
Jack Martin (Melbourne, Australia): Cellular coupling revisited. Communication between osteoblasts and osteoclasts
Jude Onyia (Indianapolis, USA): Molecular mechanisms of PTH action
Larry Raisz (Farmington, USA): Prostaglandins and bone in 2005
René Rizzoli (Geneva, Switzerland): Entering the era of the dual action bone agent
Michael Rogers (Aberdeen, UK): Molecular insights into bisphosphonate actions
Tim Spector (London, UK): Update on osteoarthritis: pathogenesis and treatment |
|
|
|
| |
| Magyar Endokrinológiai és Anyagcsere Társaság |
|
| Heart, Vessels and Diabetes European Conference |
| Rendezvény kezdete: 2010.12.01. | Rendezvény vége: 2010.12.01. |
| Szakterület(ek): Endokrinológia, anyagcsere betegségek |
| Tudományos információ: Prof. Michel KOMAJDA |
| Címe: USA, |
| Munkahely neve: HVD 2010 - PLB. Organisation Inc. c/o Guibert & Co |
| Címe: USA, NY 10016 New York, 149 East 36th street |
| Helyszín: Portugal, Lisbon, Lisbon Congress Centre |
| A rendezvény Web oldala: http://www.hvd-euroconference.com |
On behalf of the Organising Committee, it is our distinct pleasure to announce the 1st edition of the Heart, Vessels & Diabetes European Conference to be held in the capital city of Portugal, Lisbon, from 9 to 11 December 2010.
Our world is facing an epidemic of diabetes and obesity, a population at high risk of cardiovascular complications. It is therefore necessary to promote in depth discussions and collaborations amongst all the professionals concerned by the management of these patients: cardiologists, diabetologists, endocrinologists, nephrologists, neurologists
and internists.
Our ambition is that the Heart, Vessels & Diabetes Conference becomes the European reference on both cardiovascular and diabetes related issues by the creation of a unified forum where all specialists will attend common sessions and share their experience. The scientific programme will include lectures, debates, clinical case presentations as well as industry symposia. European experts will discuss the latest developments of clinical trials and clinical research and will examine their implications for daily practice.
This event of very high scientific standard with a panel of European key opinion leaders will gather a large audience of about 2,000 practitioners in cardiology, diabetes, lipids, blood pressure and related fields. As you will read within this preliminary programme, the members of the Scientific Committee are among some of the most prestigious and renowned cardiologists, diabetologists and endocrinologists in order to ensure the highest scientific level to the sessions.
The Organising Committee of the 1st edition of the Heart, Vessels & Diabetes European Conference has appointed PLB. Organisation Inc. as the official Conference Office, entrusted with the handling of all conference related arrangements.
For any information, please do not hesitate to contact the Conference Office:
PLB. Organisation Inc.
hvd2010@agence-plb.com
Web: www.hvd-euroconference.com |
|
|
|
